Purpose: The progressive ankylosis protein (ANK) is a transmembrane protein that transports intracellular pyrophosphate (PPi) to the extracellular milieu. Lack of functional ANK in ank/ank mice or ank knockout mice leads to pathological mineralization of articular cartilage, ligaments, menisci and tendons resulting in arthritic changes because of the reduced amounts of extracellular PPi, a main mineralization inhibitor. We and others, however, have shown that ANK is expressed at low levels in healthy articular cartilage, and ANK expression levels drastically increase during osteoarthritis (OA) initiation and progression. These findings raise the possibility that ANK plays more complex and unknown functions in articular cartilage and OA pathology than only preventing basic calcium crystal formation. Therefore, the purpose of this study was to determine the role of ANK in catabolic events of articular chondrocytes. Methods: The interactions of ANK with Myb-binding protein 1a (MYBBP1a) and sphingosine kinase 1 (SPHK1) were identified using yeast two-hybrid screening and co-immunoprecipitation. To determine the role of these interactions in catabolic events of articular chondrocytes, ank/ank and wild type (WT) mouse chondrocytes or femoral heads were treated with interleukin-1beta (IL-1b) in the absence or presence of the SPHK inhibitor, SKI-II. Catabolic marker mRNA levels were analyzed by real time PCR; proteoglycan loss using safranin O staining and MMP-13 immunostaining were determined in femoral head explants; NF-kB activity was determined by transfecting chondrocytes with a NF-kBspecific luciferase reporter and analyzing nuclear translocation of p65 by immunoblotting; MYBBP1a nuclear or cytoplasmic amounts were determined by immunohistochemistry and immunoblotting. Results: Yeast two-hybrid screening and co-immunoprecipitation experiments revealed that the N-terminal region of ANK interacts with SPHK1, whereas the C-terminal region interacts with MYBBP1a. MYBBP1a is a cytoplasmic protein that can shuttle into the nucleus where it represses NF-kB transcriptional activity. Consequently, the loss of ANK/MYBBP1a interactions resulted in increased MYBBP1a nuclear amounts and decreased NF-kB activity in IL-1b-treated ank/ank chondrocytes compared to IL-1b-treated WT cells. The loss of ANK/SPHK1 interaction resulted in decreased SPHK1 activity in IL-1b-treated ank/ank chondrocytes compared to IL-1b-treated WT cells. Activation of NF-kB-dependent transcriptional activity by IL-1b involves translocation of NF-kB family members, in particular p65 (RelA) and p50, from the cytoplasm to the nucleus. The increase of the nuclear p65 amount and the decrease of the cytoplasmic p65 amount in IL-1b-treated ank/ank chondrocytes were markedly reduced compared to IL-1b-treated WT cells. The SPHK inhibitor, SKI-II reduced the amount of nuclear p65 and increased the amount of cytoplasmic p65 in IL-1b-treated WTchondrocytes but not in IL-1b-treated ank/ank chondrocytes. Transfection with ank expression vector reduced nuclear MYBBP1a amounts and fully restored SPHK and NF-kB activities in IL-1b-treated ank/ank chondrocytes, whereas transfection with P5L mutant ank that does not interact with SPHK1 or F376del ank that does not interact with MYBBP1a increased SPHK activity or reduced nuclear MYBBP1a, respectively, and consequently either transfection with P5L or F376del ank only partially restored NF-kB activity. Finally, lack of ANK/ MYBBP1a and SPHK1 interactions in ank/ank chondrocytes resulted in decreased catabolic marker mRNA levels, proteoglycan loss, and MMP-13 immunostaining in IL-1b-treated articular chondrocytes or femoral heads. Conclusion: This study shows that ANK interacts via the N-terminal and C-terminal cytoplasmic regions with SPHK1 and MYBBP1a, respectively. The ANK/MYBBP1a interaction results in the inhibition of the nuclear translocation of MYBBP1a. Nuclear MYBBP1a acts as a corepressor of NF-kB transcriptional activity. The ANK/SPHK1 interaction is a major regulator of SPHK1 activity. Both interactions stimulate NF-kB activity and ultimately catabolic events in IL-1b-treated articular chondrocytes. Since IL-1b and NF-kB play major roles in OA pathogenesis, our findings suggest that increased ANK expression in OA cartilage may be a major contributor to cartilage destruction. Future experiments are needed to fully understand the mechanisms of the interactions between ANK, MYBBP1a and SPHK1 in OA pathology and develop strategies to interfere with these interactions as a potential novel therapy for the treatment of OA. Purpose: Site-1 protease (S1P) is a proprotein convertase that is primarily known for processing of latent, endoplasmic reticulum (ER) membrane-bound transcription factors SREBPs and ATF6 to their free and active form. SREBPs are involved in cholesterol and fatty acid homeostasis; ATF6 is involved in ER stress response. Cartilage-specific ablation of S1P in mice (S1P cko ) using Col2-Cre results in poor cartilage with a drastic decrease of collagen type II (Col II) in the matrix and a complete lack of endochondral bone formation, even though the molecular program for chondrocyte maturation is not disrupted. In a postnatal model using Col2-CreER T mice, ablation of S1P in postnatal chondrocytes gradually eliminates the primary growth plate with a gradual abolition of Ihh and type X collagen expression in the growth plate indicating a cessation of hypertrophic chondrocyte differentiation. The goal of this study is to understand the importance of S1P in chondrocyte maturation in the growth plate. Methods: The osterix protein is expressed in prehypertrophic chondrocytes (as well as in osteoblasts). S1P
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OSX-CRE DIRECTED ABLATION OF SITE-1 PROTEASE IN MICE RESULTS IN KYPHOSIS AND SCOLIOSIS
D. Patra, E. DeLassus, L.J. Sandell. Washington Univ. Sch. of Med., St. Louis, MO, USA Purpose: Site-1 protease (S1P) is a proprotein convertase that is primarily known for processing of latent, endoplasmic reticulum (ER) membrane-bound transcription factors SREBPs and ATF6 to their free and active form. SREBPs are involved in cholesterol and fatty acid homeostasis; ATF6 is involved in ER stress response. Cartilage-specific ablation of S1P in mice (S1P cko ) using Col2-Cre results in poor cartilage with a drastic decrease of collagen type II (Col II) in the matrix and a complete lack of endochondral bone formation, even though the molecular program for chondrocyte maturation is not disrupted. In a postnatal model using Col2-CreER T mice, ablation of S1P in postnatal chondrocytes gradually eliminates the primary growth plate with a gradual abolition of Ihh and type X collagen expression in the growth plate indicating a cessation of hypertrophic chondrocyte differentiation. The goal of this study is to understand the importance of S1P in chondrocyte maturation in the growth plate. Methods: The osterix protein is expressed in prehypertrophic chondrocytes (as well as in osteoblasts). S1P
f/f mice (homozygous for the S1P flox allele in which exon 2 of S1P is floxed) were crossed with Osx-Cre mice (in which the Cre recombinase is under the influence of the Osterix (Osx) promoter) to obtain mice with S1P ablation in prehypertrophic chondrocytes (S1P Osx mice). S1P Osx mice and wild type littermates were studied by histology, immunofluorescence, and micro-computed tomography (mCT) techniques. Results: Mice with a homozygous deletion for S1P (S1P f/f ;Osx-Cre or S1P cko-Osx mice) suffer from severe chondrodysplasia that is visible in their gross morphology beginning from postnatal day 7. Mice which are heterozygous for S1P deletion (S1P þ/f-Osx ) have a size intermediate to the S1P cko-Osx mice and their wild type littermates; additionally, these mice are also hunchbacks (kyphosis) which gets more pronounced with age.
Interestingly, mCT analysis not only confirmed the kyphosis in S1P þ/f-Osx mice, but also revealed scoliosis in the S1P cko-Osx mice. Micro-CT analysis also showed decreased bone mineralization in both mutant mice with the S1P cko-Osx mice showing a more drastic decrease than S1P þ/f-Osx mice resulting in fragile bones. In embryonic studies, S1P
cko-Osx mice exhibited a delay in the onset for endochondral bone formation, while the S1P þ/f-Osx showed normal onset of endochondral bone formation as the wild type. In immunofluorescence studies for type II collagen (Col II) distribution, while the Col2-Cre-directed S1P cko mice exhibited Col II entrapment in all zones of the growth plate including the resting and proliferative zones, S1P
cko-Osx mice showed Col II entrapment only in the hypertrophic zone, but not the resting and proliferative zones; negligible Col II entrapment was observed in the growth plate of S1P þ/f-Osx mice. Conclusions: These results indicate the indispensable nature of S1P for cartilage and overall skeletal development. S1P is essential for normal growth plate activity and cartilage formation. The current study also endorses the importance of S1P in normal skeletal development and is important for both axial and appendicular skeletal development. For the first time, we demonstrate an important functional link between S1P function(s) and diseases of the spine. These studies also suggest an indispensable role for S1P in osteoblasts. Thus understanding the contributions of S1P in cartilage, bone and vertebrae development will contribute to the understanding of overall skeletal homeostasis. Purpose: The cytokine interleukin-1b (IL-1b) stimulates a catabolic response in cartilage and has been used in vitro to model the extracellular matrix degradation seen in osteoarthritis (OA). Several groups have shown a protective effect of mechanical load and compression on IL-1b induced matrix damage in chondrocyte cultures and scaffold constructs. Torzilli et al. have demonstrated in multiple papers that this same effect is seen when applying compressive loads to cartilage explants. Our laboratory utilizes a novel in vitro cartilage loading simulator that better replicates the complex motions of loading, compression, and articulation of both the femoral condyles and tibial plateau that are seen in vivo joint articulation. Therefore, we aimed to evaluate the combined effects of articulating motion and of IL-1b on cartilage integrity in an in vitro dual-rotating system. We hypothesized that articulation would decrease the effects of IL-1b on matrix degradation as observed through the loss of glycosaminoglycans. Methods: Fresh twenty-four week old bovine stifle joints were obtained from a local abattoir. Full thickness (w3 mm) oval cartilage explants were removed by custom punch from the femoral trochlear groove. Explants were randomized into four test groups (n ¼ 4 each): articulation þ IL-1b, articulation only, no articulation þ IL-1b, and control (no articulation, no IL-1b). Explants underwent a five-day preculture in media (DMEM: F12þITS). Groups exposed to IL-1b (100 ng/ mL) experienced a one day pretreatment condition before testing, and IL-1b exposure was continued throughout the three day period. Testing was conducted in the four station joint motion simulator, housed in an incubator with 95% humidity, 5% CO2 and 37 C [ Fig. 1 ].
Explants were laterally confined in porous polyethylene platens and loaded to 40N (w2 MPa) while articulated against a ceramic ball for three hours per day for three days (ball rotation: AE30 at 0.1 Hz, explant rotation: AE15 at 0.5 Hz). Culture media was individually collected and replenished at the end of each test and rest period. Immediately after test completion on day three, explants were qualitatively examined for cell viability with LIVE/DEADÒ assay. The collected wear media from the three test days were examined for total glycosaminoglycan (GAG) content using the DMMB assay. A two-way ANOVA was used for statistical analysis of cumulative GAG release while student t-tests were used for analysis of daily GAG release with p-value less than 0.05 being significant. Results: There were no visual differences in cell viability of nonarticulated explants, regardless of exposure to IL-1b. However, articulation against the ceramic ball caused increased superficial zone cell death, regardless of exposure to IL-1b. As expected, there was a significant increase in cumulative GAG release due to the presence of IL-1b versus the absence of IL-1b (p ¼ 0.003) [Fig. 2 ].
There was a trend towards a decrease in GAG release due to articulation (p ¼ 0.087). However, no interaction between articulating motion and IL-1b was detected (p ¼ 0.8311). Significant differences in media GAG content were observed after day three of testing [ Fig. 3 ]. The media GAG content of the IL-1 treatment alone group was significantly higher than that of the other groups (p < 0.01); while the articulation alone group had a significantly lower media GAG content when compared to the other groups (p < 0.05). y as compared to no articulation þIL-1b; z as compared to no articulation, no IL-1b; U as compared to articulation þ IL-1b.
Conclusions: This study uses a novel model of joint movement to address the effects of articulating load and motion on IL-1b induced cartilage matrix damage. The data showed that the in vitro articulating motion applied in this tribosystem may be promising for minimizing the effects of IL-1b, which follows previous findings in the literature that mechanical loading decreases IL-1b matrix degradation. Based on the daily GAG release, we suspect that a longer time period would show more significant differences between the interactions of articulation and IL-1b. Future studies shall include extending the testing period as well as more extensive analysis of the media and cartilage for markers of GAG and collagen damage. Purpose: During aging and joint damage, the integrity of cartilage homeostasis is disrupted and the catabolic activity may increase; meanwhile the rate of new protein synthesis may be insufficient to maintain tissue homeostasis. These changes may vary with distance from the articular cartilage surface as well as the distance from the chondrocytes. In order to study these changes, a comprehensive analysis is needed to prevent the bias from insufficient extraction or analysis based on too few proteins. In this work, we developed a highly reproducible method for extracting and analyzing minute (1-2 mg quantities) cartilage samples to identify and quantify the guanidine-HCl extractable proteins and the non-extractable residual proteins. The final goal of this project is to obtain a molecular understanding of the joint architecture in healthy aging and disease as well as different joints by mapping the zonal organization of protein distribution pattern. Methods: We have collected cartilage samples from hips and knees (both healthy and disease) and performed transverse frozen sectioning. Sections from superficial, middle and deep layers were generated. To achieve the goals of this research, first we have optimized the procedure of extracting proteins from cartilage extracellular matrix (ECM) without confounding by intracellular proteins of chondrocytes. Chondrocytes were depleted by performing serial rapid freeze/thaw cycles in hypotonic solution. Following this, we performed conventional chaotropic guanidine-HCl extraction to obtain extractable proteins, and in situ trypsin digestion. We subsequently performed qualitative screening by Thermo Orbitrap Velos Pro MS as well as quantitative multiple reaction monitoring (MRM) using a triple quadropole instrument (TSQ-Vantage, Thermo). 
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